Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Issued
Ratios

OptimizeRx (OPRX) Shares Issued (2018 - 2025)

OptimizeRx (OPRX) has disclosed Shares Issued for 10 consecutive years, with $14000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to $14000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $120000.0 through Dec 2025, down 17.81% year-over-year, with the annual reading at $352000.0 for FY2025, N/A changed from the prior year.
  • Shares Issued hit $14000.0 in Q4 2025 for OptimizeRx, up from $1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $69.6 million in Q2 2021 to a low of $1000.0 in Q3 2023.
  • Historically, Shares Issued has averaged $7.2 million across 4 years, with a median of $162315.0 in 2022.
  • Biggest five-year swings in Shares Issued: surged 257598140.74% in 2021 and later crashed 99.54% in 2023.
  • Year by year, Shares Issued stood at $69.6 million in 2021, then crashed by 99.97% to $23377.0 in 2022, then crashed by 95.72% to $1000.0 in 2023, then surged by 1300.0% to $14000.0 in 2025.
  • Business Quant data shows Shares Issued for OPRX at $14000.0 in Q4 2025, $1000.0 in Q3 2023, and $105000.0 in Q2 2023.